This evaluation examines the possibility to license the compound before it enters clinical trials. Description of the solutions of Merck tree evaluation process are presented. The information required to evaluate specific features of licensing is provided, including the cost of the three phases of the review process, the income in the event of approval, and the probability of various outcomes. It includes an introduction to decision tree analysis and evaluation. "Hide
by Richard S. Ruback, David Krieger Source: HBS Premier Case Collection 6 pages. Publication Date: October 30, 2000. Prod. # 201 023-PDF-ENG
Related Case Solutions & Analyses:
The Drivers of Greenwashing
China s Challenge to Feed Its People
Bank of America: Mobile Banking
Working with Your Shadow Partner in Analyzing IT Strategic Planning
Cox Communications Inc.–1999
Note on the FDReview Process for Medical Devices
A Big (Double) Deal: Anadarko’s Acquisition of Kerr-McGee and Western Gas Resources
STRATEGIES FOR DEVELOPING VALUE ADDED TAX IN SAUDI ARABIA
Keirsey Style Personality – Self Assessment
Metapath Case
